3D-MSCs apoptotic bodies-integrated conductive hydrogel mitigates spinal cord injury via immunoregulation and alleviating neuronal pyroptosis.

阅读:3
作者:Zhang Jiacheng, Xiang Linyi, Cai Xiong, Geng Yibo, Wu Yuzhe, Shi Jingwei, Zhang Haojie, Hu Xinli, Jiang Xiaoqiong, Zhu Peijun, Shu Yun, Miao Ruize, Zhao Jiayi, Zhu Junsheng, Li Zhenglin, Wang Xiangyang, Xiao Jian, Zhou Kailiang, Yang Liangliang, Qi Jianjun
Spinal cord injury (SCI) is a severe condition that affects the central nervous system. Current clinical interventions are insufficient to address the profound consequences of SCI, highlighting the great need for alternative treatment options. In recent years, the use of hydrogels to locally deliver extracellular vesicles (EVs) has become a potential method for SCI therapy, conductive hydrogels can also promote SCI repair by establishing functional connections between neurons. However, increasing the bioactivity of EVs and optimizing hydrogel-based therapies remain significant challenges. In this study, MXene nanosheets endow composite hydrogels with excellent conductivity. Bone marrow mesenchymal stem cells (BMSCs) were grown in 3D suspensions to form spheroids, after which apoptosis was induced to isolate apoptotic bodies (ABs). Then 3D-ABs were incorporated into a Gelatine methacryloyl (GelMA) hydrogel containing MXene nanosheets for their sustained release in vivo. Furthermore, the composite hydrogel provides mechanical support and mimics the electrical transmission properties of neurons. After local injection into SCI mice, the composite hydrogel effectively filled the lesion cavity, promoted the reconstruction of functional neural connections, suppressed neuroinflammation and alleviated neuronal pyroptosis owing to its conductive components and apoptotic vesicles. This novel injectable composite hydrogel represents a promising therapeutic option for SCI repair.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。